The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Volition RX
Consulting or Advisory Role - Novocure
Research Funding - Epizyme; Trizell
Patents, Royalties, Other Intellectual Property - UCLA
 
Honoraria - Inventiva Pharma
Consulting or Advisory Role - Aldeyra Therapeutics; Atara Biotherapeutics; Inventiva Pharma
Speakers' Bureau - AstraZeneca; Roche
Research Funding - Astex Pharmaceuticals; Bayer; Boehringer Ingelheim
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
Safety and efficacy of tazemetostat, an enhancer of zeste-homolog 2 inhibitor, in patients with relapsed or refractory malignant mesothelioma.
 
Marjorie Glass Zauderer
Honoraria - Medical Learning Institute
Consulting or Advisory Role - Aldeyra Therapeutics; Atara Biotherapeutics; Novocure
Research Funding - Bristol-Myers Squibb (Inst); Curis (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Millennium (Inst); Polaris (Inst); Sellas Life Sciences (Inst)
Other Relationship - Roche Pharma AG
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation
 
Peter Wojciech Szlosarek
No Relationships to Disclose
 
Sylvestre Le Moulec
No Relationships to Disclose
 
Sanjay Popat
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Roche; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Guardant Health; Incyte; MSD; Novartis; Paradox Therapeutics; Pfizer; Roche; Takeda
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Epizyme (Inst); Lilly (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck Sharp & Dohme; Roche
 
Paul Taylor
No Relationships to Disclose
 
David Planchard
Honoraria - PeerVoice; Prime Oncology
Consulting or Advisory Role - AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MedImmune; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Taiho Pharmaceutical (Inst)
 
Arnaud Scherpereel
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; MSD Oncology; Roche
Speakers' Bureau - AstraZeneca; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Roche
 
Thierry Marie Jahan
Research Funding - Aduro Biotech; AstraZeneca; Bristol-Myers Squibb; Epizyme; Lilly; Polaris
(OPTIONAL) Uncompensated Relationships - Atara Biotherapeutics
 
Marianna Koczywas
Speakers' Bureau - AstraZeneca; Celgene
 
Martin Forster
Consulting or Advisory Role - Achilles Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Guardant Health; Lilly; Merck Sharp & Dohme; Nanobiotix; Novartis; Oxford VacMedix; Pfizer; PharmaMar; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Celgene; Guardant Health; MSD Oncology; Roche
 
Robert B. Cameron
No Relationships to Disclose
 
Tobias Peikert
No Relationships to Disclose
 
Evren Kocabas Argon
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Neil Michaud
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Jay Yang
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Vikram Kansra
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Dean A. Fennell
No Relationships to Disclose